Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Environmental factors and chemicals might affect hormone balance and contribute to common hair loss.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

The document helps doctors recognize and treat excessive hair growth in women.

Transgender women can still get testicular cancer, so proper screening is important.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Some women with PCOS have rare genetic variants linked to the condition.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

The healthcare for transgender veterans could be better with a more unified team approach.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.